Clinical Outcomes, Immunogenicity, and Safety of BNT162b2 Vaccine in Primary Antibody Deficiency.
Milota T, Smetanova J, Skotnicova A, Rataj M, Lastovicka J, Zelena H, Parackova Z, Fejtkova M, Kanderova V, Fronkova E, Rejlova K, Sediva A, Kalina T.
Milota T, et al. Among authors: rataj m.
J Allergy Clin Immunol Pract. 2023 Jan;11(1):306-314.e2. doi: 10.1016/j.jaip.2022.10.046. Epub 2022 Nov 13.
J Allergy Clin Immunol Pract. 2023.
PMID: 36379409